Insurance broker Aon forecasts U.S. employer healthcare costs will jump 9.5% in 2027 to over $19,000 per employee on average, driven by increased medical utilization and high-priced drug spending, representing potentially the largest increase in two decades.
New data from NHS England shows the country is nearing elimination of hepatitis C as a public health threat, with 80% of known cases cured. The progress is attributed to widespread testing initiatives including A&E blood tests, GP registration screening, and free at-home tests, along with a pioneering NHS drug deal with pharmaceutical companies.
The Michigan Supreme Court ruled 4-3 on July 31, 2026, overturning two lower court decisions and allowing Attorney General Dana Nessel to proceed with an investigation into Eli Lilly's insulin pricing practices under the Michigan Consumer Protection Act.
The U.S. Trade Representative has initiated a formal trade investigation into Germany's plan to reduce spending on pharmaceutical products, examining whether the pricing policies are unreasonable or discriminatory. The probe could result in retaliatory tariffs on German goods.
